+44 1223 790975
+44 1223 790975Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Journal of Alzheimers Disease & Parkinsonism received 3123 citations as per Google Scholar report
John Koren is a research scholar from Sloan-Kettering Cancer Centre. He is examining the mechanisms which allow some cancer-cell models to survive following Hsp90 inhibition. These studies cover cancer biology, basic Hsp90 biochemistry, signal transduction, and pharmacology. He is also studying the effects of a unique blood-brain barrier permeable Hsp90 inhibitor as a therapeutic option for neurodegenerative diseases. These studies include neurobiology, animal behavior analysis, and basic neural-biochemistry.
Neurodegenerative Diseases, Alzheimer’s Research, Cancer Biology, Molecular Neurobiology, Molecular Medicine
Chaperone-dependent Neurodegeneration: A Molecular Perspective on Therapeutic Intervention
Aaron Carman, Sarah Kishinevsky, John Koren III, Wenjie Lou and Gabriela Chiosis
Review Article: J Alzheimers Dis Parkinsonism 2013, S10-007
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 